406 related articles for article (PubMed ID: 34669196)
1. Cancer of the corpus uteri: 2021 update.
Koskas M; Amant F; Mirza MR; Creutzberg CL
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):45-60. PubMed ID: 34669196
[TBL] [Abstract][Full Text] [Related]
2. Cancer of the corpus uteri.
Amant F; Mirza MR; Koskas M; Creutzberg CL
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():37-50. PubMed ID: 30306580
[TBL] [Abstract][Full Text] [Related]
3. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
4. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Features of Recurrent Endometrial Cancer in Japan: Chemotherapy Instead of Radiotherapy as Postoperative Adjuvant Treatment.
Iwase H; Furukawa S; Hirasawa T; Asai S; Ohara T; Hosonuma S; Endo S; Tazo Y; Sato H; Takada T; Arai M; Ikeda M; Shida M; Yoshioka N; Tozawa-Ono A; Suzuki N; Mikami M; Onda T
Int J Gynecol Cancer; 2018 Oct; 28(8):1616-1623. PubMed ID: 30095709
[TBL] [Abstract][Full Text] [Related]
6. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
7. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
8. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study).
Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Sostegni B; Bellicini A; Fuso L; Cristofani R; Sartori E
Gynecol Oncol; 2014 Jul; 134(1):29-35. PubMed ID: 24769176
[TBL] [Abstract][Full Text] [Related]
10. Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer.
Nakayama K; Nagai Y; Ishikawa M; Aoki Y; Miyazaki K
Int J Clin Oncol; 2010 Oct; 15(5):440-6. PubMed ID: 20419386
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal effects of adjuvant chemotherapy and lymph node staging on patient-reported outcomes in endometrial cancer survivors: a prospective cohort study.
Forsse D; Barbero ML; Werner HMJ; Woie K; Nordskar N; Berge Nilsen E; Ellstrøm Engh M; Vistad I; Rege A; Sævik-Lode M; Andreasen S; Haldorsen IS; Trovik J; Krakstad C
Am J Obstet Gynecol; 2022 Jan; 226(1):90.e1-90.e20. PubMed ID: 34400137
[TBL] [Abstract][Full Text] [Related]
12. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.
Ørtoft G; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
[TBL] [Abstract][Full Text] [Related]
13. Analysis of failures in patients with FIGO stage IIIc1-IIIc2 endometrial cancer.
Gadducci A; Cosio S; Fabrini MG; Guerrieri ME; Greco C; Genazzani AR
Anticancer Res; 2012 Jan; 32(1):201-5. PubMed ID: 22213308
[TBL] [Abstract][Full Text] [Related]
14. Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancer.
Forsse D; Berg HF; Bozickovic O; Engerud H; Halle MK; Hoivik EA; Woie K; Werner HMJ; Haldorsen IS; Trovik J; Krakstad C
Gynecol Oncol; 2021 Feb; 160(2):396-404. PubMed ID: 33317908
[TBL] [Abstract][Full Text] [Related]
15. [The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México].
Ruvalcaba-Limón E; Cantú-de-León D; León-Rodríguez E; Cortés-Esteban P; Serrano-Olvera A; Morales-Vásquez F; Sosa-Sánchez R; Poveda-Velasco A; Crismatt-Zapata A; Santillán-Gómez A; Aguilar-Jiménez C; Alanís-López P; Alfaro-Ramírez P; Alvarez-Avitia MA; Aranda-Flores CE; Arias-Ceballos JH; Arrieta-Rodríguez O; Barragán-Curiel E; Botello-Hernández D; Brom-Valladares R; Cabrera-Galeana PA; Cantón-Romero JC; Capdeville-García D; Cárdenas-Sánchez J; Castorena-Roji G; Cepeda-López FR; Cervantes-Sánchez G; Cetina-Pérez Lde C; Coronel-Martínez JA; Cortés-Cárdenas SA; Cruz-López JC; de la Garza-Salazar JG; Díaz-Romero C; Dueñas-González A; Valle-Solís AE; Escudero-de los Ríos P; Flores-Alvarez E; García-Matus R; Gerson-Cwilich R; González-Enciso A; González-de-León C; Guevara-Torres AG; Herbert-Núñez GS; Hernández-Hernández C; Hernández-Hernández DM; Isla-Ortiz D; Jesús-Sandoval R; Jiménez-Cervantes C; Kuri-Exsome R; López-Obispo JL; Maffuz-Aziz A; Martínez-Barrera LM; Medina-Castro JM; Montalvo-Esquivel G; Mora-Aguilar VH; Morales-Palomares MA; Morán-Mendoza A; Morgan-Villela G; Mota-García A; Muñoz-González DE; Murillo-Cruz DA; Novoa-Vargas A; Ochoa-Carrillo FJ; Oñate-Ocaña LF; Ortega-Rojo A; Palacios-Martínez AG; Palomeque-López A; Pérez-Montiel MD; Quijano-Castro F; Rivera-Rivera S; Rivera-Rubí LM; Robles-Flores JU; Rodríguez-Trejo A; Salas-Gonzáles E; Silva JA; Solorza-Luna G; Souto-del-Bosque R; Tirado-Gómez LL; Torrescano-González S; Torres-Lobatón A; Trejo-Durán E; Villavicencio-Valencia V; Gallardo-Rincón D;
Rev Invest Clin; 2010; 62(6):583, 585-605. PubMed ID: 21416918
[TBL] [Abstract][Full Text] [Related]
16. A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.
Alimena S; Fiascone S; Krasner C; King M; Horowitz N
Curr Probl Cancer; 2019 Oct; 43(5):443-449. PubMed ID: 30770127
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the endometrium.
Southcott BM
Drugs; 2001; 61(10):1395-405. PubMed ID: 11558829
[TBL] [Abstract][Full Text] [Related]
19. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
